Coeliac Disease
17
3
4
10
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 17 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
20%
2 of 10 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 10 completed trials
Clinical Trials (17)
Virtual Dietetic Interventions in Patients With Coeliac
Efficacy of Symprove Probiotics in Coeliac Disease
A Phase 2a/b Study of the Efficacy and Safety of Subcutaneous Amlitelimab in Adults With Nonresponsive Celiac Disease
Diagnostic Accuracy of IgA Anti-transglutaminase Antibodies Measured by CLIA for Predicting Villous Atrophy in Coeliac Disease
A Study of Efficacy, Safety, and Tolerability of KAN-101 in People With Celiac Disease
Validation of the CDAT in the Polish Paediatric Population
A Blood Based Diagnostic Test for Coeliac Disease
Supporting Children and Young People to Live Well With Coeliac Disease: A RCT
Cardiovascular Risk Factors in Coeliac Disease: a Series of Studies
Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of GSK3915393 in Healthy Participants and to Evaluate the Interaction Between GSK3915393 and Grapefruit Juice and Itraconazole
Rapid Technique for the Detection of Intestinal Anti-transglutaminase Antibodies
MAgnetic Resonance Imaging in COeliac Disease
Bioequivalence Study of Nexvax2 in Subjects With Celiac Disease
Low FODMAPs Diet in Gastrointestinal Disorders
European Novel Motorized Spiral Endoscopy Trial
Case Finding for Coeliac Disease Using a Point of Care Test in a Pharmacy Setting
Safety Study of Nexvax2 in Subjects With Coeliac Disease